Model for End-Stage Liver Disease Exceptions in the Context of the French Model for End-Stage Liver Disease Score-Based Liver Allocation System

被引:67
作者
Francoz, Claire [1 ,8 ]
Belghiti, Jacques [2 ]
Castaing, Denis [3 ]
Chazouilleres, Olivier [4 ]
Duclos-Vallee, Jean-Charles [3 ]
Duvoux, Christophe [5 ]
Lerut, Jan [6 ]
Le Treut, Yves-Patrice [7 ]
Moreau, Richard [8 ]
Mandot, Ameet [1 ]
Pageaux, Georges [9 ]
Samuel, Didier [3 ]
Thabut, Dominique [10 ]
Valla, Dominique [1 ,8 ]
Durand, Francois [1 ,8 ]
机构
[1] Beaujon Hosp, Dept Hepatol, F-92110 Clichy, France
[2] Beaujon Hosp, Dept Hepatobiliary & Pancreat Surg, F-92110 Clichy, France
[3] Hop Paul Brousse, Hepatobiliary Ctr, Villejuif, France
[4] St Antoine Hosp, Dept Hepatol, Paris, France
[5] Henri Mondor Hosp, Dept Hepatol, Creteil, France
[6] St Luc Univ Hosp, Dept Abdominal & Transplantat Surg, Brussels, Belgium
[7] Hosp Concept, Dept Digest Surg, Marseille, France
[8] Natl Inst Hlth & Med Res, U773, Bichat Beaujon Ctr Biomed Res CRB3, Paris, France
[9] St Eloi Hosp, Dept Hepatol, Montpellier, France
[10] Hop La Pitie Salpetriere, Dept Hepatol, Paris, France
关键词
HEREDITARY HEMORRHAGIC TELANGIECTASIA; INTRAHEPATIC PORTOSYSTEMIC SHUNT; HUMAN-IMMUNODEFICIENCY-VIRUS; QUALITY-OF-LIFE; POLYTETRAFLUOROETHYLENE-COVERED STENT; NODULAR REGENERATIVE HYPERPLASIA; BUDD-CHIARI-SYNDROME; HEPATITIS-B-VIRUS; POLYCYSTIC LIVER; PORTOPULMONARY HYPERTENSION;
D O I
10.1002/lt.22363
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Model for End-Stage Liver Disease (MELD) score-based allocation systems have been adopted by most countries in Europe and North America. Indeed, the MELD score is a robust marker of early mortality for patients with cirrhosis. Except for extreme values, high pretransplant MELD scores do not significantly affect posttransplant survival. The MELD score can be used to optimize the allocation of allografts according to a sickest first policy. Most often, patients with small hepatocellular carcinomas (HCCs) and low MELD scores receive extra points, which allow them appropriate access to transplantation comparable to the access of patients with advanced cirrhosis and high MELD scores. In addition to patients with advanced cirrhosis and HCC, patients with a number of relatively uncommon conditions have low MELD scores and a poor prognosis in the short term without transplantation but derive excellent benefits from transplantation. These conditions, which correspond to the so-called MELD score exceptions, justify the allocation of a specific score for appropriate access to transplantation. Here we report the conclusions of the French consensus meeting. The goals of this meeting were (1) to identify which conditions merit MELD score exceptions, (2) to list the criteria needed for defining each of these conditions, and (3) to define a reasonable time interval for organ allocation for each MELD exception in the general context of organ shortages. MELD exceptions were discussed in an attempt to reconcile the concepts of transparency, equity, justice, and utility. Liver Transpl 17: 1137-1151, 2011. (C) 2011 AASLD.
引用
收藏
页码:1137 / 1151
页数:15
相关论文
共 123 条
[41]   THE ROLE OF ORTHOTOPIC LIVER-TRANSPLANTATION IN THE MANAGEMENT OF SCLEROSING CHOLANGITIS [J].
HARRISON, J ;
MCMASTER, P .
HEPATOLOGY, 1994, 20 (01) :S14-S19
[42]   Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma [J].
Heimbach, Julie K. ;
Gores, Gregory J. ;
Haddock, Michael G. ;
Alberts, Steven R. ;
Pedersen, Rachel ;
Kremers, Walter ;
Nyberg, Scott L. ;
Ishitani, Michael B. ;
Rosen, Charles B. .
TRANSPLANTATION, 2006, 82 (12) :1703-1707
[43]   Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death [J].
Heuman, DM ;
Abou-assi, SG ;
Habib, A ;
Williams, LM ;
Stravitz, RT ;
Sanyal, AJ ;
Fisher, RA ;
Mihas, AA .
HEPATOLOGY, 2004, 40 (04) :802-810
[44]   MELD-XI: a rational approach to "sickest first" liver transplantation in cirrhotic patients requiring anticoagulant therapy [J].
Heuman, Douglas M. ;
Mihas, Anastasios A. ;
Habib, Adil ;
Gilles, HoChong S. ;
Stravitz, R. Todd ;
Sanyal, Arun J. ;
Fisher, Robert A. .
LIVER TRANSPLANTATION, 2007, 13 (01) :30-37
[45]   Polycystic liver: clinical characteristics of patients with isolated polycystic liver disease compared with patients with polycystic liver and autosomal dominant polycystic kidney disease [J].
Hoevenaren, Inge A. ;
Wester, Ruth ;
Schrier, Robert W. ;
McFann, Kim ;
Doctor, R. Brian ;
Drenth, Joost P. H. ;
Everson, Gregory T. .
LIVER INTERNATIONAL, 2008, 28 (02) :264-270
[46]   GEOGRAPHICAL-DISTRIBUTION OF TTR MET(30) CARRIERS IN NORTHERN SWEDEN - DISCREPANCY BETWEEN CARRIER FREQUENCY AND PREVALENCE RATE [J].
HOLMGREN, G ;
COSTA, PMP ;
ANDERSSON, C ;
ASPLUND, K ;
STEEN, L ;
BEEKMAN, L ;
NYLANDER, PO ;
TEIXEIRA, A ;
SARAIVA, MJM ;
COSTA, PP .
JOURNAL OF MEDICAL GENETICS, 1994, 31 (05) :351-354
[47]   Pulmonary arterial hypertension in France - Results from a national registry [J].
Humbert, M ;
Sitbon, O ;
Chaouat, A ;
Bertocchi, M ;
Habib, G ;
Gressin, V ;
Yaici, A ;
Weitzenblum, E ;
Cordier, JFO ;
Chabot, F ;
Dromer, C ;
Pison, C ;
Reynaud-Gaubert, M ;
Haloun, A ;
Laurent, M ;
Hachulla, E ;
Simonneau, G .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 173 (09) :1023-1030
[48]   Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma [J].
Jarnagin, WR ;
Fong, Y ;
DeMatteo, RP ;
Gonen, M ;
Burke, EC ;
Bodniewicz, J ;
Youssef, M ;
Klimstra, D ;
Blumgart, LH .
ANNALS OF SURGERY, 2001, 234 (04) :507-517
[49]   Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma [J].
Khan, S. A. ;
Toledano, M. B. ;
Taylor-Robinson, S. D. .
HPB, 2008, 10 (02) :77-82
[50]   Hyponatremia and mortality among patients on the liver-transplant waiting list [J].
Kim, W. Ray ;
Biggins, Scott W. ;
Kremers, Walter K. ;
Wiesner, Russell H. ;
Kamath, Patrick S. ;
Benson, Joanne T. ;
Edwards, Erick ;
Therneau, Terry M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (10) :1018-1026